Vir Biotechnology, Inc. (VIR)
NASDAQ: VIR · Real-Time Price · USD
8.60
+0.08 (0.94%)
Jun 12, 2026, 2:57 PM EDT - Market open
Vir Biotechnology Market Cap
Vir Biotechnology has a market cap or net worth of $1.45 billion as of June 12, 2026. Its market cap has increased by 102.16% in one year.
Market Cap
1.45B
Enterprise Value
1.06B
1-Year Change
102.16%
Ranking
Category
Stock Price
$8.60
Market Cap Chart
Since October 11, 2019, Vir Biotechnology's market cap has decreased from $1.53B to $1.45B, a decrease of -5.43%. That is a compound annual growth rate of -0.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 12, 2026 | 1.45B | 72.89% |
| Dec 31, 2025 | 838.92M | -17.01% |
| Dec 31, 2024 | 1.01B | -25.30% |
| Dec 29, 2023 | 1.35B | -59.83% |
| Dec 30, 2022 | 3.37B | -38.52% |
| Dec 31, 2021 | 5.48B | 60.63% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Oct 11, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| KalVista Pharmaceuticals | 1.44B |
| ArriVent BioPharma | 1.42B |
| Immunocore Holdings | 1.42B |
| Novavax | 1.41B |
| GH Research | 1.40B |
| Monte Rosa Therapeutics | 1.40B |
| AtaiBeckley | 1.39B |
| Precigen | 1.39B |